Source: International Congress 2017 – Current challenges in COPD evaluation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
C. Páska (Budapest, Hungary). Assessment of cytokine mRNA expression in patients with COPD exacerbations. 391

Member's Comments

No comment yet.

Related content which might interest you: Analysis of cytokine gene expression after treatment and pulmonary rehabilitation of acute exacerbation in COPD Source: International Congress 2019 – Exacerbations of airway diseases Year: 2019 Change of induced sputum TNF-a and sTNF-R55,75 levels in patients with acute exacerbations of COPD Source: Annual Congress 2007 - Respiratory pathophysiology Year: 2007 MMP-9 expression and activity is incresed in the BAL of patients with acute exacerbation of COPD Source: Annual Congress 2012 - Inflammatory mechanisms in COPD Year: 2012 Association between bacterial load and inflammatory gene expression in COPD exacerbations Source: International Congress 2018 – How far are we in terms of predicting mortality and exacerbations in COPD? Year: 2018 Altered expression of glycosaminoglycans in the BAL of COPD patients with acute exacerbation Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench Year: 2013 Elevated expression of TLR4 and HBD2 depict COPD patients with acute respiratory failure Source: Eur Respir J 2007; 30: Suppl. 51, 132s Year: 2007 Cytokine receptors expression in induced sputum in asthma and COPD Source: Eur Respir J 2001; 18: Suppl. 33, 159s Year: 2001 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Th17-related cytokine expression is increased in the bronchial mucosa of stable COPD patients Source: Annual Congress 2009 - Pathology and immunology of COPD Year: 2009 Regulation of NF-kappaB-dependent cytokines during exacerbations of COPD Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Reduced expression of CD44 on lung macrophages from patients with COPD Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Changes in EBC cytokine pattern during treatment of COPD exacerbation Source: Annual Congress 2009 - Cell biology of lung disease Year: 2009 High ICAM-1 gene expression in pulmonary fibroblasts of COPD patients Source: Eur Respir J 2004; 24: Suppl. 48, 454s Year: 2004 Elevated expression of TLR4 and HBD2 but decreased levels of IP-10 in COPD with severe exacerbation Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD Year: 2008 Long-term use of ICS influence TLR2 expression on induced sputum from severe COPD patients Source: Annual Congress 2012 - Lung injury and repair: reactive oxygen species and beyond Year: 2012 Serum hyaluronidase-1 is increased in COPD exacerbations and is associated with COPD severity and outcomes Source: International Congress 2018 – Disease exacerbations from a molecular point of view Year: 2018 Variation in the TLR4 gene and airway inflammation among patients with COPD Source: Annual Congress 2009 - Genetics in the smokers corner: from inflammation in smokers via COPD to cancer Year: 2009 Enhanced expression of proinflammatory cytokine (IL-18) and its receptor in patients with chronic obstructive pulmonary disease (COPD) Source: Eur Respir J 2006; 28: Suppl. 50, 551s Year: 2006 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Expression of the β2-adrenoreceptor and M3-cholinoreceptor genes in patients with different severity of asthma and BHR level Source: Annual Congress 2012 - Phenotypes and mechanisms of treatment of asthma Year: 2012